CMR Exercise Stress Testing in HFpEF (HFpEF-Stress)
Primary Purpose
Diastolic Heart Failure
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
stress CMR
Sponsored by

About this trial
This is an interventional diagnostic trial for Diastolic Heart Failure
Eligibility Criteria
Inclusion Criteria:
- adult patients with dyspnoea under stress, echocardiographic criteria for diastolic dysfunction (E/E'>8) and clinical indication for right heart catheterisation
Exclusion Criteria:
- arrhythmia (brady- or tachycardic)
- bronchial asthma (allergic)
- incompliant patient
- pacemaker, ICD, non MRI-capable devices
- inability to use the ergometer in the MRI
- haemodynamic relevant valvular heart disease
- pulmonary disease (vital capacity or forced expiratory flow <80% of healthy control)
- angina pectoris
- post cardiac infarction
- anaemia (Hb <12 g/dl)
- uncontrollable hypertension (>150 mmHg systolic or >100 mmHg diastolic)
- age <18 years
- pregnancy
- claustrophobia
- renal insufficiency
- allergic to gadolinium based contrast agents
Sites / Locations
- University Hospital Goettingen
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
echocardiographic increase in left atrial pressure
echocardiographic no increase in left atrial pressure
Arm Description
Outcomes
Primary Outcome Measures
Cardiovascular magnetic resonance imaging
ventricular and atrial volumes
Cardiovascular magnetic resonance imaging
ventricular and atrial mechanics: strain
Cardiovascular magnetic resonance imaging
quantification of extracellular volume (ECV)/interstitial fibrosis
Secondary Outcome Measures
Full Information
NCT ID
NCT03260621
First Posted
August 10, 2017
Last Updated
November 13, 2020
Sponsor
University of Göttingen
Collaborators
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
1. Study Identification
Unique Protocol Identification Number
NCT03260621
Brief Title
CMR Exercise Stress Testing in HFpEF
Acronym
HFpEF-Stress
Official Title
Cardiovascular Magnetic Resonance Real-time Exercise Stress Testing in Heart Failure With Preserved Ejection Fraction
Study Type
Interventional
2. Study Status
Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
August 16, 2017 (Actual)
Primary Completion Date
September 1, 2019 (Actual)
Study Completion Date
September 1, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Göttingen
Collaborators
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Patients of the University Hospital Göttingen with echocardiographic signs for diastolic heart failure and indication for right heart catheterisation will undergo additional diagnostic testing with CMR including exercise stress for detailed evaluation of diastolic dysfunction and tissue characterisation correlating the results with well-established clinical standards.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diastolic Heart Failure
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
75 (Actual)
8. Arms, Groups, and Interventions
Arm Title
echocardiographic increase in left atrial pressure
Arm Type
Other
Arm Title
echocardiographic no increase in left atrial pressure
Arm Type
Other
Intervention Type
Diagnostic Test
Intervention Name(s)
stress CMR
Intervention Description
additional stress CMR to the established clinical diagnostics
Primary Outcome Measure Information:
Title
Cardiovascular magnetic resonance imaging
Description
ventricular and atrial volumes
Time Frame
approx. 1 years
Title
Cardiovascular magnetic resonance imaging
Description
ventricular and atrial mechanics: strain
Time Frame
approx. 1 years
Title
Cardiovascular magnetic resonance imaging
Description
quantification of extracellular volume (ECV)/interstitial fibrosis
Time Frame
approx. 1 years
Other Pre-specified Outcome Measures:
Title
Exercise spirometry
Description
maximal oxygen uptake
Time Frame
approx. 1 years
Title
Exercise spirometry
Description
respiratory quotient
Time Frame
approx. 1 years
Title
Exercise spirometry
Description
power (watt/kg)
Time Frame
approx. 1 years
Title
Right heart catheterization
Description
reference for intracardiac pressures: pulmonary artery pressure and pulmonary capillary wedge pressure
Time Frame
approx. 1 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
adult patients with dyspnoea under stress, echocardiographic criteria for diastolic dysfunction (E/E'>8) and clinical indication for right heart catheterisation
Exclusion Criteria:
arrhythmia (brady- or tachycardic)
bronchial asthma (allergic)
incompliant patient
pacemaker, ICD, non MRI-capable devices
inability to use the ergometer in the MRI
haemodynamic relevant valvular heart disease
pulmonary disease (vital capacity or forced expiratory flow <80% of healthy control)
angina pectoris
post cardiac infarction
anaemia (Hb <12 g/dl)
uncontrollable hypertension (>150 mmHg systolic or >100 mmHg diastolic)
age <18 years
pregnancy
claustrophobia
renal insufficiency
allergic to gadolinium based contrast agents
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andreas Schuster, MD, PhD
Organizational Affiliation
University of Göttingen
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Goettingen
City
Göttingen
ZIP/Postal Code
37073
Country
Germany
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
The data acquired within the current study will be available via the german centre for cardiovascular research (DZHK) to researchers who successfully applied to undertake additional scientific studies based on DZHK data.
Citations:
PubMed Identifier
33472397
Citation
Backhaus SJ, Lange T, George EF, Hellenkamp K, Gertz RJ, Billing M, Wachter R, Steinmetz M, Kutty S, Raaz U, Lotz J, Friede T, Uecker M, Hasenfuss G, Seidler T, Schuster A. Exercise Stress Real-Time Cardiac Magnetic Resonance Imaging for Noninvasive Characterization of Heart Failure With Preserved Ejection Fraction: The HFpEF-Stress Trial. Circulation. 2021 Apr 13;143(15):1484-1498. doi: 10.1161/CIRCULATIONAHA.120.051542. Epub 2021 Jan 21.
Results Reference
derived
Learn more about this trial
CMR Exercise Stress Testing in HFpEF
We'll reach out to this number within 24 hrs